Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Is TT virus (transfusion transmitted virus) a novel hepatotropic agent causing hepatitis?
D M Lebensztejn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children
D M Lebensztejn
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
March 20, 2002
[The methods of estimation and monitoring liver fibrosis in patients with chronic viral hepatitis]
D M Lebensztejn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Current knowledge on treatment of chronic hepatitis B in children
D M Lebensztejn, M Kaczmarski
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
September 1, 2000
[Thyroid function in children with diagnosed chronic hepatitis B treated with interferon alpha]
D M Lebensztejn, M Kaczmarski, J Wysocka, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
October 3, 2001
[The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha]
D M Lebensztejn, E Zagórecka, M Kaczmarski, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)
|
January 1, 1995
The role of free oxygen radicals in children with chronic viral hepatitis B
D M Lebensztejn, M Chwiećko, J Semeniuk, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Blind liver biopsy in children--diagnostic significance and complications in authors' own material
D M Lebensztejn, M Kaczmarski, M Sobaniec-Łotowska, et al.
Advances in Medical Sciences
|
January 26, 2008
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine
D M Lebensztejn, E Skiba, M E Sobaniec-Łotowska, et al.
Advances in Medical Sciences
|
April 8, 2010
Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD
D M Lebensztejn, D Kowalczuk, E Tarasów, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Is TT virus (transfusion transmitted virus) a novel hepatotropic agent causing hepatitis?
D M Lebensztejn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children
D M Lebensztejn
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
March 20, 2002
[The methods of estimation and monitoring liver fibrosis in patients with chronic viral hepatitis]
D M Lebensztejn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Current knowledge on treatment of chronic hepatitis B in children
D M Lebensztejn, M Kaczmarski
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
September 1, 2000
[Thyroid function in children with diagnosed chronic hepatitis B treated with interferon alpha]
D M Lebensztejn, M Kaczmarski, J Wysocka, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|
October 3, 2001
[The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha]
D M Lebensztejn, E Zagórecka, M Kaczmarski, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)
|
January 1, 1995
The role of free oxygen radicals in children with chronic viral hepatitis B
D M Lebensztejn, M Chwiećko, J Semeniuk, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 24, 2001
Blind liver biopsy in children--diagnostic significance and complications in authors' own material
D M Lebensztejn, M Kaczmarski, M Sobaniec-Łotowska, et al.
Advances in Medical Sciences
|
January 26, 2008
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine
D M Lebensztejn, E Skiba, M E Sobaniec-Łotowska, et al.
Advances in Medical Sciences
|
April 8, 2010
Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD
D M Lebensztejn, D Kowalczuk, E Tarasów, et al.
Page
of 2